Abbott’s iCGM sensors are cleared for connectivity with automated insulin delivery systems in the U.S.
Abbott announced that the U.S. Food and Drug Administration (FDA) has cleared its FreeStyle Libre 2 and FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system sensors for integration with automated insulin delivery (AID) systems.